Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate vs sufentanil for postoperative analgesia after open abdominal surgery
ChiCTR2600117288Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Time-weighted VAS score during activity from 0 to 48 hours postoperatively. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117288.